Mutations of the P53 gene, including an intronic point mutation, in colorectal tumors.
暂无分享,去创建一个
H. Shibata | R. Kanamaru | C. Ishioka | M. Gamoh | T. Yamazaki | A. Wakui | T. Sato | T. Suzuki | T. Sato
[1] K. Kinzler,et al. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. , 1991, Science.
[2] B. Vogelstein,et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. , 1990, Cancer research.
[3] J. Minna,et al. Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer. , 1990, The Journal of clinical investigation.
[4] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[5] Kathleen R. Cho,et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.
[6] F. Collins,et al. Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.
[7] J. Minna,et al. p53: a frequent target for genetic abnormalities in lung cancer. , 1989, Science.
[8] H. Shibata,et al. Mechanism of action of the synthetic imidazole compound YM 534 on human promyelocytic leukemia line HL-60 cells. , 1989, Anti-cancer drug design.
[9] D. Ledbetter,et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.
[10] I. Roninson,et al. mRNA phenotyping by enzymatic amplification of randomly primed cDNA. , 1988, Nucleic acids research.
[11] Y. Nakamura,et al. Isolation and mapping of a polymorphic DNA sequence (pYNZ22) on chromosome 17p [D17S30]. , 1988, Nucleic acids research.